Jonathan D. Root - 18 May 2023 Form 4 Insider Report for Inari Medical, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 18 May 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 May 2023, 18:05:58 UTC
Prior SEC filing: 28 Jun 2022
Next SEC filing: 30 May 2023
Source filing: View source filing
Reporting owner signature: /s/ Angela Ahmad, attorney-in-fact for Jonathan Root, M.D.

Key filing fact

Jonathan D. Root filed Form 4 for Inari Medical, Inc. on 19 May 2023.

Key facts

This page summarizes Jonathan D. Root's Form 4 filing for Inari Medical, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 May 2023, 18:05.

Change

Previous filing in this sequence was filed on 28 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NARI transaction

Common Stock

Award

Transaction value: $0
Shares: +2,412
Change %: +0.45%
Price: $0.000000
Shares after: 534,041
Date: 18 May 2023
Ownership: Direct
Footnotes: F1

NARI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 335
Date: 18 May 2023
Ownership: Directly Owned by Spouse

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents RSUs granted on May 18, 2023, to the Reporting Person that vest in full on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the 2024 annual meeting.